Work on This Study Was Conducted on the Behalf of the ITN Staycis Study Group. Investigators

Coinvestigators

Work on this study was conducted on the behalf of the ITN STAyCIS Study Group.

Investigators: S.S. Zamvil MD, PhD (Protocol Chair), E. Waubant MD, PhD (Protocol Co-

Chair), D. Pelletier MD (University of California, San Francisco, San Francisco, CA); M. Mass

MD, D. Bourdette MD, R. Egan MD (Oregon Health & Science University, Portland, OR); J.

Cohen MD, L. Stone MD (The Cleveland Clinic Foundation, Cleveland, OH); M. Kita MD, M.

Elliott MD (Virginia Mason MS Center, Seattle, WA); A. Cross MD, B.J. Parks MD

(Washington University MS Center, St. Louis, MO); A. Bar-Or MD (Montreal Neurological

Institute, Montreal, Quebec, Canada); T. Vollmer MD, D. Campagnolo MD (Barrow

Neurological Institute, Phoenix, AZ); M. Racke MD, O. Stüve MD, PhD, E. Frohman MD, PhD

(University of Texas Southwestern Medical Center, Dallas, TX); S. Schwid MD (deceased), A.

Goodman MD, B. Segal MD (University of Rochester, Rochester, NY); N. Kachuck MD, L.

Weiner MD (University of Southern California, Keck School of Medicine MS Center, Los

Angeles, CA); J. Preiningerova MD, M. Carrithers MD, PhD (Yale MS Research Center, New

Haven, CT); B. Weinstock-Guttman (Jacobs Neurological Institute, Buffalo, NY); P. Calabresi

MD, D. Kerr MD, PhD (Johns Hopkins University, Baltimore, MD); A. Miller MD, F. Lublin

MD (Mt. Sinai School of Medicine, New York, NY). ITN020AI Study Management Team: Peter

Sayre MD, PhD (Executive Director, ITN Clinical Trials Group, San Francisco, CA); Deborah

Hayes MS, Ellen Rosenberg MA, BSN, RN, Wendy Gao RN, MS (NIAID Project Managers,

Bethesda, MD); Linna Ding MD, PhD (NIAID Medical Monitor, Bethesda, MD); Steven Adah,

PhD (NIAID Senior Regulatory Officer, Bethesda MD); Masoud Mokhtarani MD, Jutta

Neuenburg MD (ITN Clinical Trial Physicians, San Francisco, CA); Carolyn Bromstead, Lynn

Olinger, Blair Mullen, Ross Jamison, Kelly Speth, Kerensa Saljooqi, Peter Phan (ITN Clinical Operations Managers, San Francisco, CA). Deborah Phippard PhD, Vicki Seyfert-Margolis PhD,

Katarzyna Bourcier PhD (ITN Trial Assay Development Analysis, Bethesda, MD); Tracia

Debnam MS, Jennifer Romaine, Stephanie Wolin, Brittany O’Dale (ITN Tolerance Research

Project Management Operations, Bethesda, MD). David Iklé PhD, Stacey Murphy MS, Heather

Kopetskie (Biostatisticians, Rho Inc., Chapel Hill, NC).